Trials / Available
AvailableNCT04837703
Managed Access Programs for ETB115, Eltrombopag
- Status
- Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this registration is to list Managed Access Programs (MAPs) related to ETB115, Eltrombopag
Detailed description
CETB115B2003I - Available - Managed Access:Treatment Plan: Individual Patient Program of Eltrombopag for Treatment of Patients with medically significant thrombocytopenia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Eltrombopag | Patients receive eltrombopag |
Timeline
- First posted
- 2021-04-08
- Last updated
- 2026-04-15
Source: ClinicalTrials.gov record NCT04837703. Inclusion in this directory is not an endorsement.